Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2026-01-02 @ 4:11 AM
Study NCT ID:
NCT00276003
Status:
COMPLETED
Last Update Posted:
2010-01-07
First Post:
2006-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
Sponsor:
University of New Mexico
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
0101C
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Ian Rabinowitz, MD; Principal Investigator
Old Organization:
University of New Mexico - CRTC